| ICD-9 PROCEDURE CODE | DESCRIPTION |
|---|---|
| 99.25 | Infusion of therapeutic substance into intraperitoneal cavity |
| ICD-9-DX CODE | DESCRIPTION |
|---|---|
| V58.1 | Encounter for chemotherapy and immunotherapy for neoplastic conditions |
| V58.11 | Encounter for antineoplastic chemotherapy |
| V58.12 | Encounter for antineoplastic immunotherapy |
| CPT PROCEDURE CODE | DESCRIPTION |
|---|---|
| 96367 | IV adtl sequential infusion for therapy, prphlxis or dx <1h |
| 96361 | Intravenous infusion, hydration each additional hr |
| 96400 | Chemo injection, sequential or intramuscular |
| 96408 | Chemo IV push, single drug |
| 96410 | Chemo IV infusion, single/initial drug, initial hour |
| 96412 | Each additional hour of infusion (up to 8 hrs) |
| 96413 | Chemo administration, up to 1 hr initial drug |
| 96414 | Initiation of prolonged chemo (>8 hrs) |
| 96415 | Each additional hr |
| 96417 | Each addtl sequential infusion (dft drug) up to 1 hr |
| 96401 | IV push intramuscular |
| CPT INJECTIBLE DRUG CODE | |
|---|---|
| J2505 | Neulasta 6 mg |
| J8705 | Topotecan |
| J8530 | Cyclophosphomide (Cytoxan) 25 mg |
| J8560 | Etoposide (Toposar)/Etopophos/VePesid |
| J9000 | Adriamycin 10 mg |
| J9001 | Doxil 10 mg |
| J9035 | Bevacizumab (avasin) 10 mg/Bevacizumab |
| J9045 | Carboplatin 50 mg/Paraplatin |
| J9060 | Cisplatin /Platinol |
| J9062 | Cisplatin /Platinol |
| J9070–J9097 | Cyclophosphomide |
| J9170 | Taxotere 20 mg/Docetaxel |
| J9181 | Etoposide (Toposar)/Etopophos/VePesid |
| J9201 | Gemzar /Gemcitabine |
| J9264 | Taxol/Paclitaxel |
| J9265 | Taxol /Paclitaxel |
| J9350 | Topotecan |
| HCPCS CODES | DESCRIPTION |
|---|---|
| G0355 | Chemo injection, sequential or intramuscular, nonhormonal agent |
| G0356 | Chemo injection, sequential or intramuscular, hormonal agent |
| G0357 | Chemo IV push, single drug |
| G0358 | Administration of each additional pushed chemo drug |
| G0359 | Chemo IV infusion, single/initial drug, initial hour |
| G0360 | Each additional hour of infusion (up to 8 hrs) |
| G0361 | Initiation of prolonged chemo (>8 hrs) |
| G0362 | Administration of each additional infused chemo drug, up to 1 hr |
| G0921–G0924 | Chemotherapy assessment for nausea and/or vomiting, patient reported |
| G0925–G0928 | Chemotherapy assessment for pain, patient reported |
| G0929–G0932 | Chemotherapy assessment for fatigue, patient reported |